Hyperactivated motility is coupled with interdependent modifications at axonemal and cytosolic levels in human spermatozoa.
Whether the motility characteristics of hyperactivated spermatozoa were determined by stable changes at the axonemal level and whether the presence of cytosolic factors was required for the expression of these changes was investigated. Different degrees of sperm hyperactivation were produced in Percoll-washed spermatozoa after incubation for 1 hour to 3 hours at 37 degrees C in Ham's F-10 supplemented with human blood plasma or fetal cord serum. Decomplemented fetal cord serum induced the highest percentage of hyperactivation (19 +/- 3%), followed by human plasma (13 +/- 2%). Fetal cord serum that was not decomplemented did not induce a level of hyperactivation (1.7 +/- 0.2%) significantly different from control levels (0.9 +/- 0.2%). Dialyzed fetal cord serum induced intermediate levels of hyperactivation (6 +/- 1%). The motility characteristics of demembranated sperm models of hyperactivated spermatozoa induced by decomplemented fetal cord serum and nonhyperactivated spermatozoa were compared by videomicroscopy and computer-assisted digital image analysis. After demembranation with Triton X-100 and reactivation of motility by Mg. adenosine triphosphate (Mg.ATP), hyperactivated and nonhyperactivated spermatozoa showed similar motility characteristics. However, hyperactivated spermatozoa that were demembranated and reactivated in cytosolic extracts from hyperactivated spermatozoa had significantly higher (P less than 0.05) linear velocity (33 +/- 4 mu/sec) and lower linearity (0.23 +/- 0.04) than control spermatozoa that were demembranated and reactivated in control cytosolic extracts (velocity = 24 +/- 1 mu/sec; linearity = 0.32 +/- 0.02). The data suggest that the expression of hyperactivated motility requires interdependent changes at the axonemal and cytosolic levels.(ABSTRACT TRUNCATED AT 250 WORDS)
Murad
C
C
Urology Research Laboratory, Royal Victoria Hospital, Montreal, Quebec, Canada.
De Lamirande
E
E
Gagnon
C
C
D000255:Adenosine Triphosphate / Q000494:pharmacology; D003600:Cytosol / Q000502:physiology* / Q000648:ultrastructure; D005312:Fetal Blood / Q000502:physiology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008870:Microtubules / Q000502:physiology* / Q000648:ultrastructure; D012984:Software; D013081:Sperm Motility / Q000502:physiology*; D013082:Sperm Tail / Q000502:physiology* / Q000648:ultrastructure; D013094:Spermatozoa / Q000502:physiology* / Q000648:ultrastructure
D000255:Adenosine Triphosphate; D008274:Magnesium